This page is updated frequently with new Skin-related patent applications.
|Electronic device using information on skin color type and control method thereof|
An electronic device and method that detects an event related to the user's skin and performs a function corresponding to the event by using information on the skin color type of the user, and further provides a control method thereof. The occurrence of an event is detected that is related to at least a part of a user's body.
Samsung Electronics Co., Ltd.
|Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors|
The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of janus kinases and are useful in the treatment of diseases related to activity of janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.. .
Incyte Holdings Corporation
|Treatment of hyperkinetic movement disorders|
Methods for treating hyperkinetic diseases and disorders, such as tardive dyskinesia, are provided. In a certain embodiment, the potent vmat2 inhibitor (+)α-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2-ol ((+)α-htbz) is used in the methods described herein for treating a subject in need thereof..
Neurocrine Biosciences, Inc.
|Pyridine and pyrazine derivative for the treatment of cf|
The present invention provides pyridine and pyrazine derivatives which restore or enhance the function of mutant and/or wild type cftr to treat cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease, asthma, respiratory tract infections, lung carcinoma, xerostomia and keratoconjunctivitis sire, or constipation (ibs, ibd, opioid induced). Pharmaceutical compositions comprising such derivatives are also encompassed..
|Matrix-metalloproteinase (mmp) inhibitory extract and methods of use thereof|
A cosmetic skin care product comprising a therapeutically effective amount of a honey extract is described, the honey extract having a phenolic compound to saccharides ratio of at least 5 times greater than the raw honey from which the extract is derived and including a mixture of at least ethanol, water and one or more mmp inhibitory phenolic compounds.. .
|N-(pyrid-4-yl)amides and n-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use|
The present invention relates generally to the field of pharmaceuticals and cosmetics. More specifically, the present invention pertains to certain n-(pyrid-4-yl)amides and n-(pyrimidin-4-yl)amides of the following formula which are potent modulators (e.g., inhibitors) of an androgen receptor, and which are useful, for example, in therapy, for example, in the treatment of a dermatological disease or disorder; a disease or disorder of the sebaceous gland(s); acne; hyperseborrhoea; oily skin; seborrhoeic dermatitis; hyperpilosity or hirsutism; atopic dermatitis; or androgenic alopecia; especially acne.
Galderma Research & Development
|Skin treatment device|
A skin treatment device includes: a shell body; a pressing bar, formed with a first end mounted in the shell body and a second end protruded from one distal end of the shell body and formed with a squeezing part having a through hole; a bactericidal lamp, installed in the shell body and including a bactericidal light source capable of generating plural bactericidal light beams passing the through hole; and a cover member, disposed at one distal end of the shell body, served to cover the second end and including a light condensing lens disposed corresponding to the through hole and the bactericidal lamp. Accordingly, when the bacteria existed on the skin or in skin pores are exposed to the bactericidal light beams, the bacteria can be naturally deceased..
Kinpo Electronics, Inc.
|Devices and methods for treating the skin|
According to some embodiments, a skin treatment assembly comprises a handpiece comprising a distal end, the handpiece comprising a recess or cavity configured to receive a cartridge or other fluid container, a tip configured to be positioned along the distal end of the handpiece, the tip being configured to contact a skin surface of a subject during use, and at least one rollerball configured to extend to or near the tip, wherein the rollerball is configured to be in fluid communication with an interior of a cartridge or other fluid container secured to the handpiece, wherein the at least one rollerball is configured to contact the skin surface of the subject during use and to facilitate the delivery of fluids to said skin surface as the rollerball is moved relative to said skin surface.. .
Edge Systems Llc
|Use of coumarin derivatives for the preparation of drugs for treating skin diseases|
Wherein n equals 0 or 1, z represents o or s, r1 represents one group chosen among the group consisting of hydrogen, c1-c7 alkyl, substituted, or not, by a halogen, a hydroxyl or a —o—r12 group, wherein r12 is a c1-c7 alkyl, a group —ch2—o—co—r5 wherein r5 is chosen among a hydrogen atom and a c1-c7 alkyl, substituted or not by at least one halogen, a group —o—r13, wherein r13 is chosen among hydrogen and a c1-c7 alkyl, an amine or a —ch2-amine, r′1 represents a group chosen among hydrogen and —o—r14, wherein r14 is chosen among hydrogen and a c1-c7 alkyl, and r2 is chosen among the group consisting of a c1-c7 alkyl, a c3-c6 cycloalkyl, an aryl group, and an heteroaryl group for the treatment of pathologies involving excess activity of at least one member of the kallikrein family.. .
|Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer|
The present invention relates to the use of a 2,5-dihydroxybenzene derivative of formula (i) or a pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the treatment and/or prophylaxis of, inter alia, skin cancer.. .
Amderma Pharmaceuticals, Llc
Heteroaromatic compounds and their use as dopamine d1 ligands
And pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating d1-mediated (or d1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), cognitive impairment (e.g., cognitive impairment associated with schizophrenia, ad, pd, or pharmacotherapy therapy), adhd, impulsivity, compulsive gambling, overeating, autism spectrum disorder, mcl, age-related cognitive decline, dementia, rls, parkinson's disease, huntington's chorea, anxiety, depression, mdd, trd, bipolar disorder, chronic apathy, anhedonia, chronic fatigue, post-traumatic stress disorder, seasonal affective disorder, social anxiety disorder, post-partum depression, serotonin syndrome, substance abuse and drug dependence, drug abuse relapse, tourette's syndrome, tardive dyskinesia, drowsiness, excessive daytime sleepiness, cachexia, inattention, sexual dysfunction, migraine, sle, hyperglycemia, atherosclerosis, dislipidemia, obesity, diabetes, sepsis, post-ischemic tubular necrosis, renal failure, hyponatremia, resistant edema, narcolepsy, hypertension, congestive heart failure, postoperative ocular hypotonia, sleep disorders, and pain.. .
Skin care system, device and method
The present invention relates to a skin care system (10), comprising: (i) a skin treatment device (12) for treating a skin of a user; (ii) a receiving unit (14) for receiving information on the skin of the user; and (iii) an evaluation unit (16) which is configured to evaluate the received information on the skin of the user and to determine based on said evaluation one or more personalized device settings for operating the skin treatment device (12). The skin treatment device (12) comprises a control unit (36) which is configured to operate the skin treatment device (12) upon initiation based on the determined one or more personalized device settings..
Koninklijke Philips N.v.
Fluid skin treatment systems and methods
The present invention relates to devices for dermatology and more particularly to fluid enhanced skin treatment system for skin rejuvenation that can optionally use an abrasive probe for removing epidermal layers while contemporaneously providing for the infusion of therapeutic fluids into the skin.. .
Use of a composition comprising arabic gum (ag) for improving gut impermeability
The use of a nutritional composition including arabic gum (ag) improves gut impermeability. The nutritional composition also improves conditions like abdominal pain, chronic or not, insomnia, bloating, flatulence, shortness of breath, gluten intolerance, malnutrition, muscle cramps, multiple chemical sensitivities, muscle pain, myofascial pain, mood swings, poor exercise tolerance, poor immunity, poor memory, recurrent skin rashes, brittle nails, hair loss, food allergies, constipation, diarrhea, liver dysfunction, brain fatigue, abdominal spasms, constant hunger pains, depleted appetite, irritable bowel syndrome, chemotherapy, food allergies, acne, liver dysfunction or inflammation of the bowel..
Luminate face mask
The present invention features novel cosmetic skin care compositions for improving the appearance of skin, particularly the reducing the appearance of age spots and discoloration.. .
Jan Marini Skin Research
Cartridges for the deposition of treatment compositions on keratinous surfaces
A micro electromechanical ink jet printing system that has a cartridge having a body that defines a core, and a die that contains one or more nozzles. There is a treatment composition contained within the cartridge core.
The Procter & Gamble Company
Methods for preparing a skin graft without culturing or use of biologics
The present invention generally relates to methods for preparing a skin graft without culturing or use of biologics. .
Kci Licensing, Inc.
Drive method and drive device of liquid crystal display
The present invention provides a drive method and a drive device of a liquid crystal display, and the drive method comprises: receiving an image to display; implementing skin color detection to the image pixels of the image to display to determine nude pixel and non skin color pixel; setting different skin color weights for the nude pixel and the non skin color pixel; implementing the color washout compensation to the image to display according to the skin color weight; driving the liquid crystal panel to show the image to display after the color washout compensation. With the aforesaid arrangement, the present invention preferably improves the resolution and viewing angle of the display at the same time..
Shenzhen China Star Optoelectronics Technology Co., Ltd.
Enforced unitasking in multitasking systems
A computer system includes one or more devices that are capable of multitasking (performing at least two tasks in parallel or substantially in parallel). In response to detecting that one of the devices is performing a first one of the tasks, the system prevents the devices from performing at least one of the tasks other than the first task (such as all of the tasks other than the first task).
Polymeric substrates with immobilized antibodies and production thereof
The present invention relates to biofunctional polymeric substrates product comprising immobilized antibodies that selective bind to antigens namely autologous growth factors and an inflammatory molecule, uses and method of production. The bio-functional polymeric substrate can be used in a quantification method of antigens namely soluble growth factors, inflammatory molecules and hormones or the biofunctional polymeric substrate can be used to isolate extracellular vesicules.
Association For The Advancement Of Tissue Engineering And Cell Based Technology And Therapie
Phototherapy apparatus with interactive user interface
A phototherapy apparatus with interactive user interface for treating biological tissue of an animal or human target. The user interface comprises intuitive graphic menus which allow the clinicians or practitioners to define the properties of the biological tissue through easily observable physical characteristics such as weight, skin color, and hair color of the patient.
Bwt Property, Inc.
Methods for applying a skin treatment
The inventive subject matter provides kits, compositions and methods for treating or covering skin using a polymerizable formulation. The polymerizable formulation can include a first component including a siloxane polymer and a catalyst, and a second component including a siloxane polymer and a cross-linker.
Methods for improving skin quality
A skin treatment regimen for delivery of a rinse-off personal skin care composition is provided. The rinse-off personal skin care composition includes varying ratios of a lathering agent to a hydrophobic benefit agent.
The Procter & Gamble Company
Diagnostic system for the detection of skin cancer
Methods and compositions are provided for the analysis of skin surfaces to determine the presence of neoplastic tissue. In the methods of the invention, a composition comprising a florescent probe that binds to a specific neoplasia associated marker is applied topically to the area of interest.
Honeycomb structure comprising a cement skin composition with crystalline inorganic fibrous material
Disclosed is a honeycomb support structure comprising a honeycomb body and an outer layer or skin formed of a cement that includes an inorganic filler material having a first coefficient of thermal expansion from 25 c to 600 c and a crystalline inorganic fibrous material having a second coefficient of thermal expansion from 25 c to 600 c. Skin cement composition controls level of cement liquid/colloid components, for example water, colloidal silica, and methylcellulose migration into the substrate during the skin application process to form barrier to skin wetting and staining during the washcoating process..
Agent for preventing or ameliorating vascular endothelial malfunction
An agent for preventing or ameliorating vascular endothelial malfunction and arteriosclerosis-related symptoms caused by the progress of vascular endothelial malfunction (e.g., ischemic diseases such as myocardial infarction, angina, and peripheral artery occlusion) or low blood flow-related symptoms (e.g., stiff shoulders, excessive sensitivity to cold, swelling, erectile dysfunction, rough skin and decrease in exercise performance due to skeletal muscle hypoactivity), which has an improved no production enhancing effect is provided. A no production enhancer comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients.
Kyowa Hakko Bio Co., Ltd.
Methods of treating dyskinesia and related disorders
The present disclosure describes compounds and pharmaceutically acceptable salts, thereof and compositions and formulations comprising the same that are useful in methods of treating dyskinesia or related disorders, and methods for treating dyskinesia or related disorders.. .
Melior Pharmaceuticals Ii, Llc
Topical compositions comprising hydroxy acids and cannabinoids for skin care
The present invention relates to compositions and methods for the prevention and treatment of skin disorders and for the rejuvenation of the skin. In particular, the application describes topical compositions and methods of treatments comprising the combined use of one or more cannabinoids and one or more hydroxy acids in a suitable carrier..
Skin graft devices and methods
Devices and methods for obtaining a plurality of skin tissue particles for use in skin grafting.. .
Kci Licensing, Inc.
Detection of borders of benign and malignant lesions including melanoma and basal cell carcinoma using a geodesic active contour (gac) technique
A method for automatic segmentation of dermoscopy skin lesion images includes automating a geodesic active contour (gac) initialization to be sufficiently large to encompass the lesion yet lie near the actual lesion contour. In addition, a new image plane is found by transforming the original rgb image to a smoothed image that allows the gac to move without sticking on the minimum local energy.
Stoecker & Associates, Llc
Ammonia-oxidizing nitrosomonas eutropha strain d23
This disclosure provides, inter alia, an optimized strain of nitrosomonas eutropha (n. Eutropha) designated d23, d23-100, or aob d23-100.
Novel pseudo ceramide compound, and pharmaceutical composition and cosmetic composition comprising same
The present invention relates to a pharmaceutical composition and a cosmetic composition, which contain, as an active ingredient, a novel pseudo compound having similar structural characteristics to natural ceramide 1, or a pharmaceutically acceptable salt or solvate thereof, and the composition containing the compound of the present invention as an active ingredient has an excellent effect of enhancing a skin barrier function, thereby exhibiting an effect of alleviating inflammatory skin diseases, and has an excellent skin barrier improving function and an excellent skin moisturization enhancing effect.. .
Neopharm Co., Ltd.
Quinoxaline derivatives as gpr6 modulators
That are gpr6 modulators and are therefore useful for the treatment of diseases treatable by modulation of gpr6, in particular treating parkinson disease, levodopa induced dyskinesias, huntington's disease, other dyskinesias, akinesias, and motor disorders involving dysfunction of the striatum, schizophrenia and drug addiction. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds..
Skin barrier function improving agent
[effect] the followings are found: a jak inhibitor increases the expression amounts of filaggrin, loricrin, involucrin and β-defensin 3 as skin barrier function-related proteins; a jak inhibitor significantly increases nmf production in a tape stripping-treated mouse; and a jak inhibitor significantly accelerates a reduction in tewl in a dry skin mouse model, namely improves the skin barrier function. The jak inhibitor can be used as an active ingredient of a therapeutic or preventive agent for skin diseases such as senile xerosis, asteatosis, eczema, contact dermatitis, ichthyosis vulgaris, netherton syndrome, type b peeling skin syndrome, etc..
Aza spiro alkane derivatives as inhibitors of metalloproteases
Enantiomer, diastereomer, prodrug, solvate, metabolite, or pharmaceutically acceptable salt thereof, wherein constituent variables are provided herein. The compounds of formula i and ii are modulators of metalloproteases and are useful in treating diseases associated with metalloprotease activity such as arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions..
2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof
Disclosed are heterocyclic compounds that are ligands for nicotinic acetylcholine receptors. The compounds are useful for treating a mammal suffering from any one of a range of therapeutic indications, including alzheimer's disease, parkinson's disease, dyskinesias, tourette's syndrome, schizophrenia, attention deficit disorder, anxiety, pain, depression, obsessive compulsive disorder, chemical substance abuse, alcoholism, memory deficit, pseudodementia, ganser's syndrome, migraine pain, bulimia, obesity, premenstrual syndrome or late luteal phase syndrome, tobacco abuse, post-traumatic syndrome, social phobia, chronic fatigue syndrome, premature ejaculation, erectile difficulty, anorexia nervosa, disorders of sleep, autism, mutism, trichotillomania, and hypothermia..
Skin treatment formulations
Dermal treatment compositions include medium recovered from an adipose-derived stem cell culture where the medium is collected under defined conditions. The medium includes growth factors and other materials that, when transported to living portions of the skin, improve the condition of damaged or aged skin.
Skin lightening compositions
As defined herein.. .
Method and system for skin blemishes layered skin treatment
A system and method for performing layer treatment for skin blemish in which the target area of the skin is first treated by performing a deep layer treatment by cutting the fibrous bands and then performing a superficial skin treatment by using electromagnetic radiation and both of the treatment take place within the same day.. .
Implantable bone marrow access apparatus
Bone marrow access apparatus includes a bone attachment part attachable to bone, a tubular conduit part attached to the bone attachment part and defining a conduit communicating with a hollow interior of the bone attachment part, and a port attached to the conduit part. The port defines a hollow interior communicating with the conduit defined by the conduit part.
Mining social media for ultraviolet light exposure analysis
Social media databases are minded for data related to a subject person. The data in indicative of a level of ultraviolet light exposure of the subject person.
International Business Machines Corporation
Skeletal joint optimization for linear blend skinning deformations utilizing skeletal pose sampling
A novel and useful mechanism for the skinning of 3d meshes with reference to a skeleton utilizing statistical weight optimization techniques. The mechanism of the present invention comprises (1) an efficient high quality linear blend skinning (lbs) technique based on a set of skeleton deformations sampled from the manipulation space; (2) a joint placement algorithm to optimize the input skeleton; and (3) a set of tools for a user to interactively control the skinning process.
Technische Universiteit Delft
Linear blend skinning weight optimization utilizing skeletal pose sampling
A novel and useful mechanism for the skinning of 3d meshes with reference to a skeleton utilizing statistical weight optimization techniques. The mechanism of the present invention comprises (1) an efficient high quality linear blend skinning (lb s) technique based on a set of skeleton deformations sampled from the manipulation space; (2) a joint placement algorithm to optimize the input skeleton; and (3) a set of tools for a user to interactively control the skinning process.
Technische Universiteit Delft
Method and device for managing memory of user device
A method and a device dynamically managing background processes according to a memory status so as to efficiently use the memory in a user device supporting a multitasking operating system. The method includes determining reference information for adjustment of the number of background processes; identifying a memory status based on the reference information; and adjusting the number of the background processes in correspondence to the memory status..
Samsung Electronics Co., Ltd
A detecting an increased risk of developing skin cancer and a use of a genotype variant of the grhl3 gene
The present invention is directed to methods of identifying snp markers associated with skin cancers, and use of these markers to explain individual susceptibility to skin cancer development. In addition, described snps have been identified as potentially crucial for proper grhl3 protein function..
Instytut Biologii Doswaidczalnej Im. M. Nenckiego Polskiej Akademii Nauk
Follow us on Twitter
This listing is a sample listing of patent applications related to Skin for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Skin with additional patents listed. Browse our RSS directory or Search for other possible listings.